Skip to content

Effect of Qi-based mindfulness therapy for mild-to-moderate depression.

Qiong-Wei Li, Yan Yang, Xue-Jiao Gao, Alexander Ma, Wei Sun

World Journal of Psychiatry April 19, 2025 DOI: 10.5498/wjp.v15.i4.104450 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Self-controlled before-after trial Peer reviewed
Sample size 18
Population Adults aged 18-65 years with mild-to-moderate depression
Intervention Qi-based mindfulness therapy (QMT)
Duration 4-week intervention, 4-week follow-up
Topics Anxiety Depression Meditation
Keywords Anxiety rating scale Depression rating scale Insomnia Qi-based mindfulness therapy
Key findings Qi-based mindfulness therapy for 4 weeks significantly reduced depression, anxiety, and insomnia symptoms in patients with mild-to-moderate depression.

Abstract

Depression is a disorder characterized by significant and persistent depressed mood, cognitive impairment, impaired voluntary activity, working memory, and somatic symptoms. To determine the efficacy of Qi-based mindfulness therapy (QMT) in treating anxiety, depression, and sleep disturbances in individuals with mild-to-moderate depression. A self-controlled before-after trial was conducted. The study invited online participants for recruitment between May and July 2023. Participants (n = 18) aged 18-65 years with mild-to-moderate depression, who were receiving QMT training for 4 weeks, were included. The primary efficacy indicators were the 17 Hamilton Depression Rating Scale and Hamilton Anxiety Scale scores. The secondary outcome indicators included the Zung Self-rating Depression Scale, the self-rating Anxiety Scale, and the Insomnia Severity Index. Pre- and post-intervention assessments were conducted. The patients' symptoms related to depression, anxiety, and insomnia were reassessed 4 weeks after the post-intervention evaluation. Patients who underwent the QMT intervention for 4 weeks exhibited a statistically significant reduction in scores on the 17 Hamilton Depression Rating Scale, Hamilton Anxiety Scale, the Zung Self-Rating Depression Scale, the Self-Rating Anxiety Scale, and the Insomnia Severity Index relative to their pre-intervention scores (all P < 0.05). QMT training for 4 weeks is an effective nonpharmacological treatment for symptoms of depression, anxiety, and insomnia among patients with mild-to-moderate depression.

Comparable studies

Other non-randomized and open-label trials on depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17

Citations in the library

Explore topics